Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Other solid neoplasm 3Thoracic 2Gynecologic 2Tumor-Agnostic 1Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Breast 1

Conditions

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Cervical Cancer Screening 1

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 90Cisplatin 67Specimen Handling 62Magnetic Resonance Spectroscopy 51olaparib 50Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Letrozole 26Doxorubicin 26Topotecan 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21Disulfides 20durvalumab 19Surveys and Questionnaires 19dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Telemedicine × Gynecologic × 1 year × Clear all
NCT07482306 2026-03-19

Telemedine

The Cleveland Clinic

Phase NA Completed
1,103 enrolled
Gynecologic

Cervical Cancer Screening

NCT06213571 2026-01-09

Remote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas

Mayo Clinic

Phase NA Active not recruiting
80 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡